Edinburgh Research Explorer

Prof John Smyth

(Former employee or visitor)

  1. Hormone therapy for epithelial ovarian cancer

    Langdon, S. P. & Smyth, J. F., 2008, In : Current opinion in oncology. 20, 5, p. 548-53 6 p.

    Research output: Contribution to journalLiterature review

  2. The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors

    Langdon, S., Faratian, D., Gourley, C., Williams, A., Um, I. H., Smyth, J. & Harrison, D., 2009, Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, p. 163-174 (Cancer Etiology, Diagnosis and Treatment Series).

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  3. Types of immunodeficiency in mice

    Langdon, S. & Smyth, J., 7 Oct 1991, The Nude mouse in Oncology Research. Taylor & Francis, p. 11-23

    Research output: Chapter in Book/Report/Conference proceedingChapter

  4. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer

    Macleod, K., Mullen, P., Sewell, J., Rabiasz, G., Lawrie, S., Miller, E., Smyth, J. F. & Langdon, S. P., 1 Aug 2005, In : Cancer Research. 65, 15, p. 6789-800 12 p.

    Research output: Contribution to journalArticle

  5. Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells

    McPhillips, F., Mullen, P., MacLeod, K. G., Sewell, J. M., Monia, B. P., Cameron, D. A., Smyth, J. F. & Langdon, S. P., Apr 2006, In : Carcinogenesis. 27, 4, p. 729-39 11 p.

    Research output: Contribution to journalArticle

  6. Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancer

    Mullen, P., McPhillips, F., MacLeod, K., Monia, B., Smyth, J. F. & Langdon, S. P., 15 Mar 2004, In : Clinical Cancer Research. 10, 6, p. 2100-8 9 p.

    Research output: Contribution to journalArticle

  7. Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling

    Mullen, P., Cameron, D. A., Hasmann, M., Smyth, J. F. & Langdon, S. P., Jan 2007, In : Molecular Cancer Therapeutics. 6, 1, p. 93-100 8 p.

    Research output: Contribution to journalArticle

  8. Comparison of strategies targeting Raf-1 mRNA in ovarian cancer

    Mullen, P., McPhillips, F., Monia, B. P., Smyth, J. F. & Langdon, S. P., 15 Mar 2006, In : International Journal of Cancer. 118, 6, p. 1565-71 7 p.

    Research output: Contribution to journalArticle

  9. Adrenal carcinoma treated with chemotherapy can result in prolonged survival

    Nussey, F., Seckl, J. & Smyth, J., Apr 2004, In : Clinical Oncology. 16, 2, p. 157-158 2 p.

    Research output: Contribution to journalLetter